Efektivitas Pengobatan Massal Filariasis Setelah Empat Tahun Pengobatan Massal di Desa Ploso, Demak, Jawa Tengah
Abstract
TThe filariasis elimination program is carried out through mass treatment with Diethylcarbamazine Citrate (DEC) and albendazole once a year for five years. Filariasis mass treatment, which was carried out for five years, aims to reduce the prevalence rate of microfilaria < 1%. Evaluation of community treatment needs to be done, one of which is the Finger Blood Preparation (SDJ) and Polymerase Chain Reaction (PCR) methods. The purpose of this research was to know the effectiveness of mass treatment of filariasis after four years in Karang Ploso Village, Demak, Indonesia. This study is a descriptive study with a cross-sectional approach with a sample of 350 people. The study variables were an examination of SDJ microfilariae, PCR molecular examination, and interviews about filariasis knowledge. The examination methods used were SDJ and PCR. The data analysis used was univariate, microfilaria rate. The results of SDJ and PCR examinations were not found microfilariae, so that the Mf rate was 0%. As many as 97.4% of people adhered to taking medication, 91.1% of people had moderate knowledge of filariasis, 98.3% had an average experience of the Mass Drug Administration (MDA). The Mf rate results by SDJ and PCR in Demak after the fourth filariasis treatment program in 2019 was 0%. There was a decrease in SDJ results from 2016-2019, namely 1% to 0% in 2019.
References
2. Departemen Kesehatan Republik Indonesia. Epidemiologi filariasis. Jakarta: Direktorat Jendral PP&PL; 2008.
3. Buku Pegangan Alat Bantu: Panduan Pelaksanaan bagi Petugas Kesehatan di Indonesia, GTZSISKES & Depkes, 2004.
4. Amarillo ML, Belizario VY Jr, Sadiang-Abay JT, Sison SA, Dayag AM. Factors associated with the acceptance of mass drug administration for the elimination of lymphatic filariasis in Agusan del Sur, Philippines. Parasit Vectors. 2008;1(1):14. doi:10.1186/1756-3305-1-14.
5. Dinas Kesehatan Provinsi Jawa Tengah. Profil kesehatan Propinsi Jawa Tengah Tahun 2010. Semarang: Dinas Kesehatan Provinsi Dati I Jateng; 2011.
6. Dinas Kesehatan Kota Demak. Laporan P2P Dinas Kesehatan Kota Demak. Demak: Dinas Kesehatan Kota Demak; 2016.
7. Dinas Kesehatan Kota Demak. Laporan P2P Dinas Kesehatan Kota Demak. Demak: Dinas Kesehatan Kota Demak; 2019.
8. Hussain MA, Sitha AK, Swain S, Kadam S, Pati S. Mass drug administration for lymphatic filariasis elimination in a coastal state of India: a study on barriers to coverage and compliance. Infect Dis Poverty. 2014;3(31). doi: 10.1186/2049-9957-3-31.
9. Fischer P, Supali T, Maizels RM. Lymphatic flariasis and Brugia timori: prospects for elimination. Trend Parasitol. 2004;20(8):351-5.
10. Hendri J, Ipa M, Ginanjar A, Yuliasih Y,Astuti EP. 2018. Intervensi kader dalam mendukung program pemberian obat massal pencegahan (POMP) filariasis di Kecamatan Cibeureum dan Cibingbin, Kabupaten Kuningan. J Ekol Kesehat. 2018;17(1):31-40. doi:10.22435/jek.17.1.138.31-40.
11. Erlich HA. Basic methodology. In: Erlich HA, editor. PCR technology: principles and applications for DNA amplification. New York:Stockton Press; 1989. p.1-5.
12. Ferlianti R. Optimalisasi real time PCR untuk diagnosis filariasis bancrofti pada sediaan hapus darah tebal. Jurnal Kedokteran Yarsi. 2012;20(1):14-22. doi:10.33476/jky.v20i1.154.
13. Arini, Sawaraswati LD, Ginandjar P, Martini Prevalensi filariasis dan gambaran pengobatan masal di wilayah kerja Puskesmas Jembatan Mas Kabupaten Batang Hari. Jurnal Kesehatan Masyarakat (e-Journal). 2018;6(1):178–90.
14. Ambarita LP, Taviv Y, Sitorus H, Pahlepi RI, Kasnodihardjo K. Perilaku masyarakat terkait penyakit kaki gajah dan program pengobatan massal di Kecamatan Pemayung Kabupaten Batanghari, Jambi. Media Litbangkes. 2014;24(4), 191–8.
15. Abdullah M. Metodelogi penelitian kuantitatif. Yogyakarta: Aswaja Pressindo; 2015.
16. Arikunto S. Prosedur penelitian suatu pendekatan praktik. Jakarta: Rineka Cipta; 2010.
17. Santoso S, Suryaningtyas NH. Spesies mikrofilaria pada penderita kronis filariasis secara mikroskopis dan polymerase chain reaction (PCR) di Kabupaten Tanjung Jabung Timur. Media Litbangkes. 2015;25(4):249–56. doi:10.22435/mpk.v25i4.4592.249-256.
18. Badan Pusat Statistik Kabupaten Demak. Kecamatan Karngtengah dalam angka 2019. Demak: BPS; 2019.
19. Juhairiyah, Fakhrizal D, Hidayat S, Indriyati L, Hairani B. Kepatuhan masyarakat minum obat pencegah massal filariasis (kaki gajah): studi kasus Desa Bilas, Kabupaten Tabalong. Jurnal Vektor Penyakit. 2019;13(1):49-58. doi: 10.22435/vektorp.v13i1.956.
20. Kementerian Kesehatan RI. Rencana nasional program akselerasi eliminasi filariasis di Indonesia 2010 – 2014. Jakarta: Subdit Filariasis dan Schistomiasis Direktorat P2B2, Ditjen PP dan PL. Kemenkes RI; 2016.
21. CDC. 2010. Biology - life cycle of wuchereria bancrofti. diakses pada tanggal 14 april 2020, dari https://www.cdc.gov/parasites/lymphaticfilariasis/ biology_w_bancrofti.html.
22. Santoso, Saikhu A, Taviv Y, Yuliani R., Mayasari R, Supardi. Kepatuhan masyarakat terhadap pengobatan massal filariasis di Kabupaten Belitung Timur tahun 2008. Bul Penelitian Kesehatan. 2010;38(4):185-97.
23. Cuomo MJ. Noel LB, White DB. Diagnosing medical parasites: a public health officers guide to assisting laboratory and medical officers [report]. Air Education and Training Command; 2009.
24. Rosanti TI, Mardihusodo SJ, Artama WT. Directly observed treatment increases drug compliance in lymphatic filariasis mass drug administration. Universa Medicina. 2016;35(2), 119–27. doi:10.18051/UnivMed.2016.v35.i2.
25. Suherni. Faktor-faktor yang berhubungan dengan perilaku minum obat filariasis pada kegiatan pengobatan massal filariasis di Kabupaten Subang Jawa Barat Tahun 2007 [skripsi]. Depok: Universitas Indonesia; 2008.
26. Nurlaila, Praba Ginandjar M. Faktorfaktor yang berhubungan dengan Kepatuhan Pengobatan Masal di Kelurahan Non Endemis Filariasis Kota Pekalongan. J Kesehat Masy. 2017;5 Nomor 4:455-466. https://ejournal3.undip.ac.id/index.php/j km/article/view/18662. Accessed March.
27. Safitri A. Identifikasi vektor dan vektor potensial daerah endemis filariasis di Kalimantan Selatan. Tanah Bumbu: Balai Litbang P2B2 Tanah Bumbu; 2011.
28. Rahayu N. Faktor yang berhubungan dengan penularan filariasis di Puskesmas Lasung Kec. Kusan Hulu Kab. Tanah Bumbu Propinsi Kalimantan Selatan [Tesis]. Yogyakarta: Universitas Gadjah Mada; 2008.
29. Majawati, E. S. (2014). Penggunaan Polymerase Chain Reaction (PCR) pada Diagnosis Filariasis. Jurnal Kedokteran Meditek, 15(39B). https://doi.org/10.36452/jkdoktmeditek.v15i39B.873.
30. Chesnais CB, Missamou F, Pion SD, Bopda J, Louya F, Majewski AC, et al. A case study of risk factors for lymphatic flariasis in the Republic of Congo. Parasites & Vectors. 2014;7:300. doi:10.1186/1756-3305-7-300.
31. Elytha F. Transmission assesment survei sebagai salah satu langkah penentuan eliminasi filariasis. Jurnal Kesehatan Masyarakat Andalas. 2014;8(2):85-92. doi:10.24893/jkma.v8i2.131.
32. Freedman D.O. 2002 Host Factors, Parasite Factors, and External Factors Involved in the Pathogenesis of Filarial Infections. In: The Filaria. World Class Parasites, vol 5. Springer, Boston, MA. https://doi.org/10.1007/0-306-47661-4_7.
33. Klei TR, TV Rajan (eds.). World class Parasites: Volume 5. The Filaria. Host factors, parasite factors, and external factors involved in the pathogenesis of fillarial infections. [internet]. New York, Boston, Dordrecht, London, Moscow: Kluwer Academic Publisher, 2002. [cited 2008 Dec 29]. Available from: http://kluweronline.com and http://ebooks.kluweronline.com.
34. McCarthy J, Zhong M, Gopinath R, Ottesen E, Williams S, Nutman T. Evaluation of a polymerasechain reaction-based assay for diagnosis of Wuchereria bancrofti infection. J Infect Dis1996;173:1510–1514. [PubMed: 8648232.
35. Nandha. Analisis spasial faktor-faktor risiko kejadian filariasis di Kabupaten Agam Propinsi Sumatera Barat Tahun 2007 [tesis]: Yogyakarta: Universitas Gadjah Mada; 2007.
36. Sularno S, Raharjo M, Nurjazuli. Faktor-faktor yang berhubungan dengan kejadian filariasis di Kecamatan Buaran Kabupaten Pekalongan. Jurnal Kesehatan Lingkungan Indonesia. 2017;16(1):22-8. doi:10.14710/jkli.16.1.22-28.
37. Weerasooriya MV, Yahathugoda CT, Wickramasinghe D, Gunawardena KN, Dharmadasa RA, Vidanapathirana KK, et al. Social mobilisation, drug coverage and compliance and adverse reactions in a mass drug administration (MDA) programme for the elimination of lymphatic filariasis in Sri Lanka. Filaria J. 2007;6:11. doi: 10.1186/1475-2883-6-11.
38. Kumar A, Sachan P. Measuring impact on filarial infection status in a community study: role of coverage of mass drug administration (MDA). Tropical Biomedicine. 2014;31(2), 225–9.
39. Masrizal. Penyakit filariasis. Jurnal Kesehatan Masyarakat. 2012;7(1):32-8. doi:10.24893/jkma.v7i1.105.
40. Perni SG, Motghare DD, Ferreira AM, Perni SS, Vaz FS, Kulkarni MS et al. Evaluation of mass drug administration for elimination of lymphatic filariasis in Goa, India. International Journal of Community Medicine and Public Health. 2015;2(3):259–62. doi:10.18203/2394-6040.ijcmph20150479.
41. Siwiendrayanti A, Pawenang ET, Indarjo S, Windraswara R. Edukasi pencegahan filariasis dengan buku saku mandiri di wilayah endemis filariasis Kabupaten Demak. Abdimas. 2019;23(2):107–11. doi:10.15294/abdimas.v23i2.17878.
Copyright (c) 2021 BALABA
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
The Authors submitting a manuscript do so on the understanding that if accepted for publication, the copyright of the article shall be assigned to BALABA .
Copyright encompasses exclusive rights to reproduce and deliver the article in all forms and media, including reprints, photographs, microfilms, and any other similar reproductions, as well as translations. The reproduction of any part of this journal, its storage in databases, and its transmission by any form or media, such as electronic, electrostatic, and mechanical copies, photocopies, recordings, magnetic media, etc., will be allowed only with written permission from BALABA.
BALABA, the Editors, and the Editorial Board make every effort to ensure that no wrong or misleading data, opinions or statements be published in this journal.
Click here to download Copyright Transfer Form.
